⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17656838 | 1.00 | — | — | |
| SCHEMBL17656834 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28850631 | 0.97 | — | — | |
| SCHEMBL18744218 | 0.77 | — | — | |
| SCHEMBL15105881 | 0.77 | TSHR (0.38) | — | |
| SCHEMBL1054318 | 0.75 | — | — | |
| SCHEMBL17656840 | 0.75 | — | — | |
| SCHEMBL2447626 | 0.75 | — | — | |
| SCHEMBL6956010 | 0.75 | — | — | |
| SCHEMBL1940063 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109180459-A | The synthetic method of the fluoro- 2,2- neopentanoic acid of 3,3,3- tri- | 海门瑞医药科技有限公司 | 2019-01-11 | — | — | CN | claimed |
| EP-2994169-A1 | LABELLED CARBOXYLIC ACIDS AND THEIR USES IN MOLECULAR IMAGING | Imperial Innovations Ltd (GB) | 2016-03-16 | — | — | EP | claimed |
| EP-4747258-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | Tenvie Therapeutics, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20260092061-A1 | COMPOUNDS FOR TARGETED PROTEIN DEGRADATION | AMPHISTA THERAPEUTICS LTD (GB) | 2026-04-02 | — | — | US | disclosed |
| EP-4637843-A2 | METHODS AND MATERIALS FOR COMBINING BIOLOGICS WITH MULTIPLE CHELATORS | Mayo Foundation for Medical Education and Research (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4559912-A1 | SULFUR-CONTAINING HETEROAROMATIC RING COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | Evopoint Biosciences Co., Ltd. (CN) | 2025-05-28 | — | — | EP | disclosed |
| CN-119677515-A | Treatment of fibrotic diseases using metabotropic glutamate receptor 5 antagonists or/and cannabinoid receptor 1 antagonists | 美国政府健康及人类服务部 | 2025-03-21 | — | — | CN | disclosed |
| CN-119522220-A | Sulfur-containing heteroaromatic compounds, pharmaceutical compositions thereof and uses thereof | 苏州信诺维医药科技股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119390542-A | Method for synthesizing heptafluoro-n-propyl ether by taking hexafluoropropylene oxide as raw material | 湖南天氟新材料有限公司 | 2025-02-07 | — | — | CN | disclosed |
| WO-2025024329-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | NICO THERAPEUTICS, INC. (US) | 2025-01-30 | — | — | WO | disclosed |
| EP-4486455-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2025-01-08 | — | — | EP | disclosed |
| WO-2010029082-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-03-18 | — | — | WO | disclosed |
| WO-2009080694-A1 | THIAZOLE DERIVATIVES USED AS PI 3 KINASE INHIBITORS | NOVARTIS AG (CH) | 2009-07-02 | — | — | WO | disclosed |
| US-20090163469-A1 | Organic Compounds | NOVARTIS AG | 2009-06-25 | — | — | US | disclosed |
| US-7365223-B2 | Method for selective targeting of apoptotic cells and small molecule ligands used thereof | NST NEUROSURVIVAL TECHNOLOGIES LTD (IL) | 2008-04-29 | — | — | US | disclosed |
| EP-1045836-B1 | PYRIDONES AS SRC FAMILY SH2 DOMAIN INHIBITORS | BOEHRINGER INGELHEIM PHARMA (US) | 2008-03-05 | — | — | EP | disclosed |
| WO-2005000824-A1 | LAZOLIDINE DERIVATIVES AS HERBICIDAL AGENTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2005-01-06 | — | — | WO | disclosed |
| CN-1398840-A | Prepn of aliphatic fluoride | PIM INVESTMENT SCIENT PRODUCTI (RU) | 2003-02-26 | — | — | CN | disclosed |
| US-4898608-A | Pyridylthio-acylanilide herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 1990-02-06 | — | — | US | disclosed |
| US-4627871-A | Herbicidal 2-[4-substituted carboxyamino-phenoxy (or phenyl mercapto)]-substituted pyrimidines | BAYER AKTIENGESELLSCHAFT (DE) | 1986-12-09 | — | — | US | disclosed |